This document is a translation of the Japanese language original for information purposes and is prepared as a guide for non-Japanese shareholders. In the event of a discrepancy, the Japanese original version shall prevail.
June 20, 2025
NOTICE OF RESOLUTIONS AT
THE 160TH ORDINARY GENERAL MEETING OF SHAREHOLDERS
It is our pleasure to inform you that the following items were reported and resolved at the 160th Ordinary General Meeting of Shareholders of Nitto Denko Corporation (the "Company") held today.
Items reported: 1. Business Report, Consolidated and Non-Consolidated Financial Statements for the 160th term (from April 1, 2024 to March 31, 2025)
2. Auditing results of Consolidated Financial Statements by Accounting Auditors and the Board of Corporate Auditors
Items resolved:
Item 1: Approval of the proposed dividends from surplus
This item was approved as originally proposed (the year-end dividend is 28 yen per share).
Item 2: Election of ten Directors
As originally proposed, the ten candidates, namely Hideo Takasaki, Yosuke Miki, Yasuhiro Iseyama, Yasuhito Ohwaki, Tatsuya Akagi, Yoichiro Furuse, Wong Lai Yong, Michitaka Sawada, Yasuhiro Yamada and Mariko Eto were elected as Directors and they assumed their offices.Wong Lai Yong, Michitaka Sawada, Yasuhiro Yamada and Mariko Eto are Outside Directors stipulated in Item 15, Article 2 of the Companies Act of Japan.
Attachments
Original document
Permalink
Disclaimer
Nitto Denko Corporation published this content on June 20, 2025, and is solely responsible for the information contained herein. Distributed via Public Technologies (PUBT), unedited and unaltered, on June 20, 2025 at 08:09 UTC.
NITTO DENKO CORPORATION is a Japan-based company mainly engaged in the industrial tape business, the optronics business and the life science business. The Company operates in three business segments. The Industrial Tapes segment is engaged in the manufacture and sale of basic functional materials such as bonding materials and protective materials, as well as automotive materials. The Optronics segment is engaged in the manufacture and sale of information functional materials, printed circuits and process materials. The Life Science segment is engaged in the manufacture and sale of medical related materials. The Company is also engaged in the manufacture and sale of polymer separation membranes and other products.
This super rating is the result of a weighted average of the rankings based on the following ratings: Global Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Global Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite), and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be performed. We recommend that you carefully review the associated descriptions.
Quality
Quality
This composite rating is the result of an average of the rankings based on the following ratings: Capital Efficiency (Composite), Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully review the associated descriptions.
ESG MSCI
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
